Long-term adjuvant immunotherapy in stage I high risk malignant melanoma, comparing two BCG preparations versus non-treatment in a randomised multicentre study (EORTC Protocol 18781). (Q43796500)
Jump to navigation
Jump to search
scientific article published in January 1993
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Long-term adjuvant immunotherapy in stage I high risk malignant melanoma, comparing two BCG preparations versus non-treatment in a randomised multicentre study (EORTC Protocol 18781). |
scientific article published in January 1993 |
Statements
1 reference
Long-term adjuvant immunotherapy in stage I high risk malignant melanoma, comparing two BCG preparations versus non-treatment in a randomised multicentre study (EORTC Protocol 18781). (English)
1 reference
Czarnetzki BM
1 reference
Macher E
1 reference
Suciu S
1 reference
Thomas D
1 reference
Steerenberg PA
1 reference
Rümke P
1 reference
1 January 1993
1 reference
1 reference
29A
1 reference
9
1 reference
1237-1242
1 reference
Identifiers
1 reference
1 reference